Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 4/20 | 0.43 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | FASN | P49327 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.35 |
| ▸ | USP5 | P45974 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | CCR2 | P41597 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14002670 | 1.00 | ESR2 (0.43) | ESR2USP30HTR2AHTR2CHTR2B | |
| SCHEMBL18503350 | 0.95 | ESR2 (0.40) | ESR2USP30HTR2AHTR2CHTR2B | |
| SCHEMBL14228805 | 0.95 | ESR2 (0.40) | ESR2USP30HTR2AHTR2CHTR2B | |
| SCHEMBL2741542 | 0.90 | ESR2 (0.43) | ESR2USP30HTR2AHTR2CHTR2B | |
| SCHEMBL9979948 | 0.90 | ESR2 (0.52) | ESR2USP30HTR2AHTR2CHTR2B | |
| SCHEMBL22031146 | 0.88 | ESR2 (0.41) | ESR2CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL7507561 | 0.87 | CYP2C9 (0.50) | ESR2USP30HTR2AHTR2CHTR2B | |
| SCHEMBL7756551 | 0.87 | CYP2C9 (0.40) | ESR2USP30HTR2AHTR2CHTR2B | |
| SCHEMBL7594396 | 0.87 | CYP2C9 (0.50) | ESR2USP30HTR2AHTR2CHTR2B | |
| SCHEMBL7511645 | 0.87 | CYP2C9 (0.40) | ESR2USP30HTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11193066-B2 | Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display device and use thereof | JNC CORPORATION (JP) | 2021-12-07 | — | — | US | disclosed |
| EP-3725764-A1 | POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JNC Corporation (JP) | 2020-10-21 | — | — | EP | disclosed |
| EP-3722278-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2020-10-14 | — | — | EP | disclosed |
| US-10759998-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display element | JNC CORPORATION (JP) | 2020-09-01 | — | — | US | disclosed |
| EP-3305774-B1 | BENZOTHIOPHENE-CONTAINING LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2020-08-26 | — | — | EP | disclosed |
| EP-3495450-B1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2020-08-05 | — | — | EP | disclosed |
| EP-3406585-B1 | TETRACYCLIC LIQUID CRYSTAL COMPOUND HAVING DIATOMIC BONDING GROUP AND 2,3-DIFLUOROPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2020-07-29 | — | — | EP | disclosed |
| US-10676669-B2 | Compound having naphthalene ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-06-09 | — | — | US | disclosed |
| EP-3257839-B1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2019-09-04 | — | — | EP | disclosed |
| EP-3495450-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2019-06-12 | — | — | EP | disclosed |
| US-8956550-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2015-02-17 | — | — | US | disclosed |
| US-20140293213-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140077131-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2014-03-20 | — | — | US | disclosed |
| US-20130208227-A1 | SWITCH ELEMENT COMPRISING A LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2013-08-15 | — | — | US | disclosed |
| US-20130208227-A1 | SWITCH ELEMENT COMPRISING A LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2013-08-15 | — | — | US | disclosed |
| WO-2012052100-A1 | SWITCH ELEMENT COMPRISING A LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2012-04-26 | — | — | WO | disclosed |
| US-7714977-B2 | Liquid crystal optical modulation element and optical head device | ASAHI GLASS COMPANY, LIMITED (JP) | 2010-05-11 | — | — | US | disclosed |
| US-7449222-B2 | Liquid-crystalline medium | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-11-11 | — | — | US | disclosed |
| US-7449222-B2 | Liquid-crystalline medium | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-11-11 | — | — | US | disclosed |
| US-20070104895-A1 | LIQUID CRYSTAL OPTICAL MODULATION ELEMENT AND OPTICAL HEAD DEVICE | ASAHI GLASS COMPANY, LIMITED (JP) | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11193066-B2 | Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display device and use thereof | OCIAD2, PYM1, C1S | ESR2 4495/4885USP30 3297/4885HTR2A 1375/4885 |
| US-10676669-B2 | Compound having naphthalene ring, liquid crystal composition and liquid crystal display device | PYM1, CXCR1, CPNE4 | ESR2 1913/4885USP30 4600/4885HTR2A 1866/4885 |
| US-10759998-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display element | SP1, SFXN3, SFXN1 | ESR2 2449/4885USP30 4768/4885HTR2A 4086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.